Objective: FDG PET/CT has a growing role in the diagnosis and management of nasopharyngeal carcinoma (NPC). FDG PET has greater efficacy for N and M staging than other modalities, which enables the treating oncologists to select the appropriate mode of treatment. FDG PET/CT helps in radiation therapy planning, provides valuable prognostic information, and is useful in the assessment of therapy response and in follow-up to detect recurrences.
Conclusion: FDG PET/CT is a valuable imaging test in the management of NPC.
Keywords: PET/CT; nasopharyngeal cancer; patient outcome; radiation therapy planning.